Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-65.73	49.04	-143.10
Graham Fair Price	inf	0.00	24.82
PEG	inf	0.00	< 0.005
Price/Book	inf	0.00	2.77
Price/Cash Flow	inf	0.00	93.76
Prices/Earnings	inf	0.00	-8.82
Price/Sales	inf	0.00	11.79
Price/FCF	inf	0.00	93.76
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	104.55	0.39	0.19
Operating Margin	-92.13	0.02	-0.27
ROA	89.07	< 0.005	-0.02
ROE	-0.08	< 0.005	88.79
ROIC	-0.02	< 0.005	-91.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	850.80
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.97	1.10	-72.24
EPS QOQ	-26.32	0.87	-96.69
FCF QOQ	-0.16	-1.46	-796.34
Revenue QOQ	-0.25	0.29	13.07
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.68	15.82	0.88
Days Sales Outstanding (DSO)	425.46	330.16	-22.40
Inventory Turnover	5.74	5.69	-0.88
Debt/Capitalization	0.63	0.64	0.97
Quick Ratio	0.59	0.52	-11.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.67	0.00	inf
Cash	0.70	0.00	inf
Capex	-1.25	0.00	inf
Free Cash Flow	0.55	0.00	inf
Revenue	4.39	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.83	0.81	-2.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-53.70	49.04	-8.67
Naive Interpretation	Member

06 - Financial Health · Bad

Rating